Found 7 matching trials
A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers
PHASE1Debio 1450-103 is a trial to study the pharmacokinetics (PK) of an experime...
Location
Early Phase Clinical Unit
A Single Dose Study of Debio 1450 in Healthy Subjects
PHASE1The sponsor is trying to develop a medicine for infections that are not cur...
Location
Early Phase Clinical Unit
Study of Debio 1450 for Bacterial Skin Infections
PHASE2The primary objective of this study is to evaluate the efficacy of 2 differ...
Location
Dream Team Clinical Research, LLC
Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
PHASE1Debio 1450 is being developed for the treatment of staph (staphylococcal) i...
A Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects
PHASE1Debio 1450 is metabolised mainly by CYP3A4, therefore inhibitors of CYP3A4 ...
Location
Covance Clinical Research Unit Ltd.
Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus
PHASE2This is a randomized, active-controlled, open-label study to assess the saf...
Location
Georgian Clinics JSC
Renal Impairment Pharmacokinetics (PK) Trial of Afabicin
PHASE1The primary purpose of this study is to assess the effect of renal impairme...
Location
Charite Research Organisation